Telemedicine 3.0: The real anywhere and anytime

Authors

• Hiroyuki Takao, Department of Innovation for Medical Information Technology, The Jikei University School of Medicine, Tokyo, Japan.
• Kohei Takeshita, Department of Innovation for Medical Information Technology, The Jikei University School of Medicine, Tokyo, Japan.
• Kenichiro Sakai, Department of Neurology, The Jikei University School of Medicine, Tokyo, Japan.
• Teppei Komatsu, Department of Neurology, The Jikei University School of Medicine, Tokyo, Japan.
• Teppei Sakano, Department of Innovation for Medical Information Technology, The Jikei University School of Medicine, Tokyo, Japan.
• Yu Chih Yeh, Department of Innovation for Medical Information Technology, The Jikei University School of Medicine, Tokyo, Japan.
• Demetrius K. Lopes, Advocate Health - MidwestFollow
• Raul G. Nogueira, Division of Cerebrovascular Medicine, UPMC Stroke Institute, Pittsburgh, PA, USA.
• Sheila Martins, Department of Neurology and Neurosurgery, Hospital Moinho dos Ventos, Porto Alegre, RS, Brazil.
• Shigeru Kawada, Department of Innovation for Medical Information Technology, The Jikei University School of Medicine, Tokyo, Japan.
• Issei Kan, Department of Neurosurgery, The Jikei University School of Medicine, Tokyo, Japan.
• Toshihiro Ishibashi, Department of Neurosurgery, The Jikei University School of Medicine, Tokyo, Japan.
• Yasuyuki Iguchi, Department of Neurology, The Jikei University School of Medicine, Tokyo, Japan.
• Yuichi Murayama, Department of Neurosurgery, The Jikei University School of Medicine, Tokyo, Japan.

Recommended Citation

Takao H, Takeshita K, Sakai K, et al. Telemedicine 3.0: The Real Anywhere and Anytime. J Neuroendovasc Ther. 2025;19(1):2024-0103. doi:10.5797/jnet.ra.2024-0103

Affiliations

Advocate Illinois Masonic Medical Center

Abstract

Clinical applications of telemedicine using digital technology are in demand in Japan and continue to expand. However, with some exceptions, it would be difficult to say that the current situation is adequate in terms of encouraging research and development, formulating guidelines that need to be established before telemedicine can spread, and providing support programs for these activities. The "Telestroke" telemedicine system for the treatment of stroke has been adopted in other countries due to the early establishment of a medical device program compatible with guidelines and the steady accumulation of evidence, creating a situation that leads the world. With optimization of the support program from the perspective of strategically produced evidence by governments and related organizations, and by taking these results as model cases for other regions, telemedicine in Japan is thought to progress to a new stage.

Document Type

Article

PubMed ID

40486915